Eli Lilly CEO announces it will cap out-of-pocket costs for its insulin at $35
The announcement follows the implementation of the Inflation Reduction Act’s $35 cap on out-of-pocket insulin costs for Medicare recipients.
By Oliver Willis - March 02, 2023